Department of Surgery, Massachusetts General Hospital, Boston, MA 02114, USA.
Eur J Immunol. 2010 May;40(5):1369-74. doi: 10.1002/eji.200940046.
Involvement of Treg in transplant tolerance has been demonstrated in multiple models. During the active process of graft rejection, these regulatory cells are themselves regulated and inactivated, a process termed counter-regulation. We hypothesize that ligation of the costimulatory molecule glucocorticoid-induced TNF receptor-related protein (GITR) on Treg inhibits their ability to promote graft survival, and by blocking GITR ligation graft survival can be prolonged. To this aim, we have designed a soluble GITR fusion protein (GITR-Fc), which binds GITR ligand and inhibits activation of GITR. Here, we show that GITR-Fc prolonged mouse skin graft survival, and this prolongation is dependent on Treg. In a full MHC-mismatched skin graft setting, GITR-Fc significantly improved graft survival when used in combination with MR1, anti-CD40L, while GITR-Fc alone did not demonstrate graft prolongation. These results demonstrate that disruption of binding of GITR with GITR ligand may be an important strategy in prolonging allograft survival.
调节性 T 细胞(Treg)在移植耐受中的作用已在多种模型中得到证实。在移植物排斥的活跃过程中,这些调节性细胞自身受到调节和失活,这一过程称为反向调节。我们假设在 Treg 上交联共刺激分子糖皮质激素诱导的 TNF 受体相关蛋白(GITR)会抑制其促进移植物存活的能力,并且通过阻断 GITR 交联可以延长移植物存活时间。为此,我们设计了一种可溶性 GITR 融合蛋白(GITR-Fc),它可以结合 GITR 配体并抑制 GITR 的激活。在这里,我们显示 GITR-Fc 可延长小鼠皮肤移植物的存活时间,并且这种延长依赖于 Treg。在完全 MHC 错配的皮肤移植物设置中,当 GITR-Fc 与 MR1、抗 CD40L 联合使用时,可显著改善移植物的存活,而单独使用 GITR-Fc 并不能延长移植物的存活。这些结果表明,破坏 GITR 与 GITR 配体的结合可能是延长同种异体移植物存活时间的重要策略。